|
Compound class:
Synthetic organic
Comment: KY0418 is an orally bioavailable, covalent inhibitor of glutathione peroxidase 4 (GPX4) that selectivity targets the enzyme's catalytic selenocysteine 46 (SeCys46) residue [1]. It is proposed as a tool to further in vivo ferroptosis research and explore ferroptosis induction as a mechanism to suppress tumour progression.
Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Naowarojna N, Gu X, Pan Z, Yu J, Huang K, Zeng Y, Xie Y, Zhang Y, Wang F, Mao J et al.. (2026)
A bioavailable GPX4 inhibitor for ferroptosis induction in vivo and tumor suppression. Cell, [Epub ahead of print]. [PMID:42906540] |